<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00629668</url>
  </required_header>
  <id_info>
    <org_study_id>KMUH-IRB-940189</org_study_id>
    <nct_id>NCT00629668</nct_id>
  </id_info>
  <brief_title>Genetic Polymorphisms of TNF-Î± Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaohsiung Medical University Chung-Ho Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaohsiung Medical University Chung-Ho Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prognosis of Hepatitis B virus (HBV)infection varies from minimal progressive liver
      disease to cirrhosis or hepatocellular carcinoma (HCC).Both viral and host genetic factors
      contribute to disease severity. Cytokine gene polymorphism has been regarded affecting
      prognosis of disease. By detecting HBV genotyping and tumor necrosis factor-alpha
      polymorphism, this study aime to assess their effects and interaction on disease severity of
      HBV-related chronic liver disease and HCC.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2007</start_date>
  <completion_date type="Anticipated">December 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cytokine gene polymorphism</measure>
    <time_frame>years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>cytokine gene polymorohism on severity of disease</measure>
    <time_frame>years</time_frame>
  </secondary_outcome>
  <condition>Chronic Liver Disease</condition>
  <condition>Hepatocellular Carcinoma</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>TNF-alpha and HBV genotype</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TNF-alpha and HBV genotypes</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HBV-positive patients

        Exclusion Criteria:

          -  HBV-negative patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jen-Eing Jeng, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor of Clinical Laboratory</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kaohsiung Medical University Chung-Ho Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>807</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jen-Eing Jeng, M.D.</last_name>
      <phone>886-7-3121101</phone>
      <phone_ext>7223</phone_ext>
      <email>jejeng @cc.kmu.edu.tw</email>
    </contact>
    <investigator>
      <last_name>Jen-Eing Jeng, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>July 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2008</study_first_submitted>
  <study_first_submitted_qc>March 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2008</study_first_posted>
  <last_update_submitted>March 5, 2008</last_update_submitted>
  <last_update_submitted_qc>March 5, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 6, 2008</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

